Table: Modalis Therapeutics - 9-MTH group results

Modalis Therapeutics

05/11/2020 06:00

Nov 5 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2020        Sep 30, 2019     Dec 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            340 mln                                        
  Operating     loss 168 mln                                      
  Recurring     loss 209 mln                                      
  Net           loss 214 mln                                      
  EPS           loss 8.34 yen                                     
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T